针对溶解体进行增强的抗癌疗法和免疫反应
Michal Stark1, Yehuda G Assaraf1
1The Fred Wyszkowski Cancer Research Laboratory, Faculty of Biology, The Technion-Israel Institute of Technology, Haifa 3200003, Israel.
International journal of biological sciences
|February 16, 2026
概括
针对细胞废物降解和自过程中至关重要的 lysosomes,可以增强癌症治疗. 调节溶酶体可以提高化疗和放射治疗的疗效,减少副作用,并提高抗癌免疫力.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症治疗,如化疗和放射治疗,通过改变新陈代谢和瘤微环境,导致副作用和瘤耐药性.
- lysosomes 是酸性细胞器,对细胞平衡和自至关重要,这种途径通常在癌细胞中增强,以求生存和免疫逃避.
- 瘤中增强的自能保护抗化疗,抑制抗癌免疫反应,有助于癌症的进展.
研究的目的:
- 探索向溶酶体的潜力,以改善癌症治疗结果.
- 研究溶酶体调节器如何影响自,免疫反应和瘤生长.
- 讨论策略,以最大限度地减少溶酶体向癌症治疗的不良影响.
主要方法:
- 经典和创新的溶酶体调节器的审查.
- 分析它们对自流的影响.
- 对它们对抗癌症免疫反应和瘤转移的影响的评估.
主要成果:
- 色素向可以减轻自流,可能克服治疗阻力.
- lysosomes 的调节可以增强抗癌免疫反应.
- 瘤生长和转移的抑制可以通过针对溶酶体的策略来实现.
结论:
- 溶解体在瘤学中是一个有前途的治疗点.
- lysosome调节器提供了一种提高常规癌症治疗和免疫反应的策略.
- 通过有针对性的输送和组合疗法来最大限度地减少副作用对于临床应用至关重要.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Lysosomes
26.6K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
26.6K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Delivery Pathways to the Lysosome
10.3K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.3K
Modified-Release Drug Delivery Systems: Site-Targeted
18
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18


